{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T03:15:26Z","timestamp":1780974926194,"version":"3.54.1"},"reference-count":194,"publisher":"Walter de Gruyter GmbH","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,6,27]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The results of several recent experimental studies using animal models and clinical trials suggested that obesity is not merely an epiphenomenon or a prominent comorbidity in patients with heart failure (HF). Indeed, recent studies suggest that obesity is intimately involved in the pathogenesis of HF with preserved ejection fraction (HFpEF). The most recent studies indicate that approximately 50% of HF patients have HFpEF. As standard pharmacological treatment usually shows only a weak or even neutral effect on primary outcomes in patients with HFpEF, treatment strategies targeted to specific groups of HFpEF patients, such as those with obesity, may increase the likelihood of reaching substantial clinical benefit. Considering the well-known inverse relationship between body mass index (BMI) values and B-type natriuretic peptide (BNP) levels, it is theoretically conceivable that the measurement of natriuretic peptides, using cutoff values adjusted for age and BMI, should increase diagnostic and prognostic accuracy in HFpEF patients. However, further experimental studies and clinical trials are needed to differentiate and better understand specific mechanisms of the various HFpEF phenotypes, including obese HFpEF.<\/jats:p>","DOI":"10.1515\/cclm-2017-0840","type":"journal-article","created":{"date-parts":[[2018,1,30]],"date-time":"2018-01-30T10:01:00Z","timestamp":1517306460000},"page":"1015-1025","source":"Crossref","is-referenced-by-count":24,"title":["Obese phenotype and natriuretic peptides in patients with heart failure with preserved ejection fraction"],"prefix":"10.1515","volume":"56","author":[{"given":"Aldo","family":"Clerico","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Zaninotto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Passino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Plebani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","reference":[{"key":"ref1681","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jacc.2011.01.005","article-title":"Pro-B-type natriuretic peptide 1-108 circulates in the general community: plasma determinants and detection of left ventricular systolic dysfunction","volume":"57","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"ref1861","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/oby.2011.296","article-title":"Brain Natriuretic Peptide Subgroup of the Look AHEAD Research Group. Impact of the Look AHEAD intervention on NT-pro brain natriuretic peptide in overweight and obese adults with diabetes","volume":"20","year":"2012","journal-title":"Obesity Res"},{"key":"ref931","first-page":"1119","article-title":"Lipolytic effects of B-type natriuretic peptide 1-32 in adipose tissue of heart failure patients compared with healthy controls","volume":"58","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/CIRCULATIONAHA.116.021884","article-title":"Phenotype-specific treatment of heart failure with preserved ejection fraction: a multiorgan roadmap","volume":"134","year":"2016","journal-title":"Circulation"},{"key":"ref1581","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/HJH.0b013e3282f624a0","article-title":"Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans","volume":"26","year":"2008","journal-title":"J Hypertens"},{"key":"ref1191","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11897-015-0257-5","article-title":"Sarcopenic obesity and the pathogenesis of exercise intolerance in heart failure with preserved ejection fraction","volume":"12","year":"2015","journal-title":"Curr Heart Fail Rep"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1038\/emm.2016.20","article-title":"Crosstalk between the heart and peripheral organs in heart failure","volume":"48","year":"2016","journal-title":"Exp Mol Med"},{"key":"ref1791","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1161\/CIRCHEARTFAILURE.113.000887","article-title":"Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial","volume":"7","year":"2014","journal-title":"Circ Heart Fail"},{"key":"ref1621","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1210\/jc.2011-1182","article-title":"Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies","volume":"96","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"ref441","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/jama.2013.2024","article-title":"Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial","volume":"309","year":"2013","journal-title":"J Am Med Assoc"},{"key":"ref561","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/MAJ.0b013e318271c012","article-title":"Obesity, brain natriuretic peptide levels and mortality in patients hospitalized with heart failure and preserved left ventricular systolic function","volume":"345","year":"2013","journal-title":"Am J Med Sci"},{"key":"ref1011","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ejhf.110","article-title":"Prevalence of unrecognized heart failure in older persons with shortness of breath on exertion","volume":"16","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"ref1261","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/jama.2015.17346","article-title":"Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure and preserved ejection fraction a randomized, controlled trial","volume":"315","year":"2016","journal-title":"J Am Med Assoc"},{"key":"ref631","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1210\/jc.2011-1182","article-title":"Cardiac natriuretic peptides, obesity, and insulin resistance: evidence from two community-based studies","volume":"96","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa020245","article-title":"Obesity and the risk of heart failure","volume":"347","year":"2002","journal-title":"N Engl J Med"},{"key":"ref1441","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/CIRCHEARTFAILURE.110.959890","article-title":"Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial","volume":"4","year":"2011","journal-title":"Circ Heart Fail"},{"key":"ref1251","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1001\/jama.1995.03530240025035","article-title":"Effects of weight loss vs aerobic exercise training on risk factors for coronary disease in healthy, obese, middle-aged and older men. A randomized controlled trial","volume":"274","year":"1995","journal-title":"J Am Med Assoc"},{"key":"ref1331","doi-asserted-by":"crossref","first-page":"e540","DOI":"10.1016\/j.orcp.2013.12.005","article-title":"Mechanisms of heart failure in obesity","volume":"8","year":"2014","journal-title":"Obes Res Clin Pract"},{"key":"ref371","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1161\/CIRCRESAHA.107.156596","article-title":"Leptin signaling and obesity: cardiovascular consequences","volume":"101","year":"2007","journal-title":"Circ Res"},{"key":"ref1311","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1515\/hmbci-2014-0013","article-title":"Crosstalk between adipose tissue and blood vessels in cardiometabolic syndrome: implication of steroid hormone receptors (MR\/GR)","volume":"19","year":"2014","journal-title":"Horm Mol Biol Clin Investig"},{"key":"ref1391","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.hfc.2012.06.003","article-title":"Sphingolipids, lipotoxic cardiomyopathy, and cardiac failure","volume":"8","year":"2012","journal-title":"Heart Fail Clin"},{"key":"ref1721","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.abb.2008.04.007","article-title":"A glycosylated form of the human cardiac hormone pro B-type natriuretic peptide is an intrinsically unstructured monomeric protein","volume":"475","year":"2008","journal-title":"Arch Biochem Biophys"},{"key":"ref1731","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1373\/clinchem.2008.113373","article-title":"Processing of pro-brain natriuretic peptide is suppressed by O-glycosylation in the region close to the cleavage site","volume":"55","year":"2009","journal-title":"Clin Chem"},{"key":"ref1521","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cca.2012.07.017","article-title":"State of the art of BNP and NT-proBNP immunoassays: the CardioOrmoCheck study","volume":"414","year":"2012","journal-title":"Clin Chim Acta"},{"key":"ref451","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1161\/CIRCHEARTFAILURE.110.959890","article-title":"Body mass index and adverse cardiovascular outcomes in heart failure patients with preserved ejection fraction: results from the Irbesartan in Heart Failure with Preserved Ejection Fraction (I-PRESERVE) trial","volume":"4","year":"2011","journal-title":"Circ Heart Fail"},{"key":"ref611","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jacc.2011.03.042","article-title":"Influence of sex and hormone status on circulating natriuretic peptides","volume":"58","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"ref1041","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jacc.2013.02.092","article-title":"A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation","volume":"62","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"ref911","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1210\/jc.2009-0051","article-title":"Aerobic exercise training improves atrial natriuretic peptide and catecholamine-mediated lipolysis in obese women with polycystic ovary syndrome","volume":"94","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"ref1761","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1373\/clinchem.2016.265397","article-title":"Unraleveling the molecular complexity of O-glycosylated endogenous (N-Terminal) pro_B-type natriuretic peptide forms in blood plasma of patients with severe heart failure","volume":"63","year":"2017","journal-title":"Clin Chem"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.cardfail.2011.01.013","article-title":"High prevalence of sleep apnea in heart failure outpatients: even in patients with preserved systolic function","volume":"17","year":"2011","journal-title":"J Card Fail"},{"key":"ref1431","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/jama.2013.2024","article-title":"Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial","volume":"309","year":"2013","journal-title":"J Am Med Assoc"},{"key":"ref711","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.abb.2006.03.028","article-title":"The precursor to B-type natriuretic peptide is an O-linked glycoprotein","volume":"451","year":"2006","journal-title":"Arch Biochem Biophys"},{"key":"ref1301","doi-asserted-by":"crossref","first-page":"46","DOI":"10.5049\/EBP.2013.11.2.46","article-title":"Obesity associated hypertension: new insights into mechanism","volume":"11","year":"2013","journal-title":"Electrolyte Blood Press"},{"key":"ref1551","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1097\/MAJ.0b013e318271c012","article-title":"Obesity, brain natriuretic peptide levels and mortality in patients hospitalized with heart failure and preserved left ventricular systolic function","volume":"345","year":"2013","journal-title":"Am J Med Sci"},{"key":"ref351","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1161\/CIRCRESAHA.115.307765","article-title":"Increased epicardial adipose tissue volume correlates with cardiac sympathetic denervation in patients with heart failure","volume":"118","year":"2016","journal-title":"Circ Res"},{"key":"ref1461","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1093\/clinchem\/42.10.1627","article-title":"Analytical performance and clinical usefulness of a commercially available IRMA kit for the measurement of atrial natriuretic peptide in patients with heart failure","volume":"42","year":"1996","journal-title":"Clin Chem"},{"key":"ref1901","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1210\/jc.2009-0051","article-title":"Aerobic exercise training improves atrial natriuretic peptide and catecholamine-mediated lipolysis in obese women with polycystic ovary syndrome","volume":"94","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"ref1591","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1080\/14728222.2016.1254198","article-title":"Targeting cardiac natriuretic peptides in the therapy of diabetes and obesity","volume":"20","year":"2016","journal-title":"Expert Opin Ther Targets"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/eurjhf\/hfr036","article-title":"Heart failure diagnosis and prognosis in the elderly: the proof of the pudding is in the eating","volume":"13","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"ref1951","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pharmthera.2014.04.007","article-title":"Metabolic actions of natriuretic peptides and therapeutic potential in the metabolic syndrome","volume":"144","year":"2014","journal-title":"Pharmacol Ther"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.amjcard.2013.12.031","article-title":"Skeletal muscle composition and its relation to exercise intolerance in older patients with heart failure and preserved ejection fraction","volume":"113","year":"2014","journal-title":"Am J Cardiol"},{"key":"ref731","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.abb.2008.04.007","article-title":"A glycosylated form of the human cardiac hormone pro B-type natriuretic peptide is an intrinsically unstructured monomeric protein","volume":"475","year":"2008","journal-title":"Arch Biochem Biophys"},{"key":"ref501","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0735-1097(03)00787-3","article-title":"Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath","volume":"42","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.116.026807","article-title":"Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction","volume":"136","year":"2017","journal-title":"Circulation"},{"key":"ref1371","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1042\/CS20070166","article-title":"Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome","volume":"114","year":"2008","journal-title":"Clin Sci"},{"key":"ref1661","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1373\/clinchem.2006.076141","article-title":"The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure","volume":"53","year":"2007","journal-title":"Clin Chem"},{"key":"ref1281","doi-asserted-by":"crossref","first-page":"e217","DOI":"10.1038\/emm.2016.20","article-title":"Crosstalk between the heart and peripheral organs in heart failure","volume":"48","year":"2016","journal-title":"Exp Mol Med"},{"key":"ref401","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.hfc.2012.06.003","article-title":"Sphingolipids, lipotoxic cardiomyopathy, and cardiac failure","volume":"8","year":"2012","journal-title":"Heart Fail Clin"},{"key":"ref1501","doi-asserted-by":"crossref","first-page":"D102","DOI":"10.1093\/eurheartj\/sux027","article-title":"ANMCO\/ELAS\/SIBioC consensus document: biomarkers in heart failure","volume":"19","year":"2017","journal-title":"Eur Heart J Suppl"},{"key":"ref581","doi-asserted-by":"crossref","first-page":"H12","DOI":"10.1152\/ajpheart.00226.2011","article-title":"60. Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones","volume":"301","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref1841","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jacc.2013.03.038","article-title":"Higher natriuretic peptide levels associate with a favorable adipose tissue distribution profile","volume":"62","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"ref1091","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/jama.1991.03470020057032","article-title":"The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study","volume":"266","year":"1991","journal-title":"J Am Med Assoc"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jacc.2016.05.019","article-title":"The HFpEF obesity phenotype. The elephant in the room","volume":"68","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"ref261","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1001\/jama.1995.03530240025035","article-title":"Effects of weight loss vs aerobic exercise training on risk factors for coronary disease in healthy, obese, middle-aged and older men. A randomized controlled trial","volume":"274","year":"1995","journal-title":"J Am Med Assoc"},{"key":"ref1741","first-page":"832","article-title":"Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure","volume":"76","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"ref1111","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jchf.2013.01.006","article-title":"Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure","volume":"1","year":"2013","journal-title":"JACC Heart Fail"},{"key":"ref831","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","article-title":"The perindopril in elderly people with chronic heart failure (PEP-CHF) study","volume":"27","year":"2006","journal-title":"Eur Heart J"},{"key":"ref1971","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ijcard.2016.04.111","article-title":"Potent influence of obesity on suppression of plasma B-type natriuretic peptide levels in patients with acute heart failure: an approach using covariance structure analysis","volume":"215","year":"2016","journal-title":"Int J Cardiol"},{"key":"ref801","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1161\/CIRCHEARTFAILURE.113.000887","article-title":"Cardiac structure and function in heart failure with preserved ejection fraction: baseline findings from the echocardiographic study of the treatment of preserved cardiac function heart failure with an aldosterone antagonist trial","volume":"7","year":"2014","journal-title":"Circ Heart Fail"},{"key":"ref331","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cca.2014.09.006","article-title":"Markers of fibrosis, inflammation, and remodeling pathways in heart failure","volume":"443","year":"2015","journal-title":"Clin Chim Acta"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s11897-015-0257-5","article-title":"Sarcopenic obesity and the pathogenesis of exercise intolerance in heart failure with preserved ejection fraction","volume":"12","year":"2015","journal-title":"Curr Heart Fail Rep"},{"key":"ref1231","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3945\/ajcn.112.047860","article-title":"Associations between body composition and gait-speed decline: results from the Health, Aging, and Body Composition study","volume":"97","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"ref1691","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0009-8981(03)00240-7","article-title":"Characterization of molecular forms of probrain natriuretic peptide in human plasma","volume":"334","year":"2003","journal-title":"Clin Chim Acta"},{"key":"ref421","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.jacc.2013.11.035","article-title":"Risk of myocardial infarction and heart failure among metabolically healthy but obese individuals. The HUNT Study, Norway","volume":"63","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"ref1361","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1161\/CIRCRESAHA.107.156596","article-title":"Leptin signaling and obesity: cardiovascular consequences","volume":"101","year":"2007","journal-title":"Circ Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/ejhf.304","article-title":"Heart failure with preserved ejection fraction: uncertainties and dilemmas","volume":"17","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"ref491","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0140-6736(94)92690-5","article-title":"Plasma brain natriuretic peptide in assessment of acute dyspnoea","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"ref1421","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jacc.2016.04.052","article-title":"Functional status, pulmonary artery pressure, and clinical outcomes in heart failure with preserved ejection fraction","volume":"68","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"ref1671","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1373\/clinchem.2007.090266","article-title":"Analysis of circulating forms of proBNP and NT-proBNP in patients with severe heart failure","volume":"54","year":"2008","journal-title":"Clin Chem"},{"key":"ref601","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1080\/14728222.2016.1254198","article-title":"Targeting cardiac natriuretic peptides in the therapy of diabetes and obesity","volume":"20","year":"2016","journal-title":"Expert Opin Ther Targets"},{"key":"ref1641","first-page":"B37","article-title":"Nonenzymatic glycosylation: role in the pathogenesis of diabetic complications","volume":"32","year":"1986","journal-title":"Clin Chem"},{"key":"ref1541","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.hfc.2014.04.006","article-title":"Natriuretic peptides in heart failure with preserved ejection fraction","volume":"10","year":"2014","journal-title":"Heart Fail Clin"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.jacc.2014.08.036","article-title":"Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction","volume":"64","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"ref1161","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/CIRCULATIONAHA.117.028365","article-title":"Obese heart failure with preserved ejection fraction phenotype: from pariah to central player","volume":"136","year":"2017","journal-title":"Circulation"},{"key":"ref151","first-page":"85","article-title":"A clinical approach to obstructive sleep apnea as a risk factor for cardiovascular disease","volume":"12","year":"2016","journal-title":"Vasc Health Risk Manag"},{"key":"ref951","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1172\/JCI59701","article-title":"Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes","volume":"122","year":"2012","journal-title":"J Clin Invest"},{"key":"ref1051","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/CIRCULATIONAHA.116.021884","article-title":"Phenotype-specific treatment of heart failure with preserved ejection fraction: a multiorgan roadmap","volume":"134","year":"2016","journal-title":"Circulation"},{"key":"ref1321","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.cca.2014.09.006","article-title":"Markers of fibrosis, inflammation, and remodeling pathways in heart failure","volume":"443","year":"2015","journal-title":"Clin Chim Acta"},{"key":"ref1491","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/S0735-1097(03)00787-3","article-title":"Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath","volume":"42","year":"2003","journal-title":"J Am Coll Cardiol"},{"key":"ref461","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.amjcard.2012.05.014","article-title":"Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction","volume":"110","year":"2012","journal-title":"Am J Cardiol"},{"key":"ref641","doi-asserted-by":"crossref","first-page":"527","DOI":"10.7326\/0003-4819-101-4-527","article-title":"Nonenzymatic glycosylation and the pathogenesis of diabetic complications","volume":"101","year":"1984","journal-title":"Ann Intern Med"},{"key":"ref671","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1373\/clinchem.2006.076141","article-title":"The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure","volume":"53","year":"2007","journal-title":"Clin Chem"},{"key":"ref1871","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.biochi.2015.05.017","article-title":"Natriuretic peptide control of energy balance and glucose homeostasis","volume":"124","year":"2016","journal-title":"Biochimie"},{"key":"ref1031","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/ejhf.304","article-title":"Heart failure with preserved ejection fraction: uncertainties and dilemmas","volume":"17","year":"2015","journal-title":"Eur J Heart Fail"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1093\/eurheartj\/ehu204","article-title":"New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes","volume":"35","year":"2014","journal-title":"Eur Heart J"},{"key":"ref701","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0009-8981(03)00240-7","article-title":"Characterization of molecular forms of probrain natriuretic peptide in human plasma","volume":"334","year":"2003","journal-title":"Clin Chim Acta"},{"key":"ref781","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1373\/clinchem.2007.097998","article-title":"Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NT-proBNP assays: preliminary observations from the IFCC Committee for Standardization of Markers of Cardiac Damage","volume":"54","year":"2008","journal-title":"Clin Chem"},{"key":"ref901","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1249\/01.mss.0000170124.51659.52","article-title":"Training enhances ANP lipid-mobilizing action in adipose tissue of overweight men","volume":"37","year":"2005","journal-title":"Med Sci Sports Exercise"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1042\/CS20070166","article-title":"Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome","volume":"114","year":"2008","journal-title":"Clin Sci"},{"key":"ref571","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10741-011-9249-z","article-title":"The paradox of low BNP levels in obesity","volume":"17","year":"2012","journal-title":"Heart Fail Rev"},{"key":"ref841","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","volume":"362","year":"2003","journal-title":"Lancet"},{"key":"ref1611","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2006.10.040","article-title":"Associations among androgens, estrogens, and natriuretic peptides in young women: observations from the Dallas Heart Study","volume":"49","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"ref1081","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1161\/CIRCULATIONAHA.116.026807","article-title":"Evidence supporting the existence of a distinct obese phenotype of heart failure with preserved ejection fraction","volume":"136","year":"2017","journal-title":"Circulation"},{"key":"ref411","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1161\/CIRCULATIONAHA.106.632745","article-title":"Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction","volume":"114","year":"2006","journal-title":"Circulation"},{"key":"ref1711","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1373\/clinchem.2007.100040","article-title":"Immunodetection of glycosylated NT-proBNP circulating in human blood","volume":"54","year":"2008","journal-title":"Clin Chem"},{"key":"ref1381","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S1388-1981(02)00342-6","article-title":"Lipoapoptosis: its mechanism and its diseases","volume":"1585","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"ref1511","first-page":"762","article-title":"Proficiency testing project for brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) immunoassays: the CardioOrmocheck study","volume":"47","year":"2009","journal-title":"Clin Chem Lab Med"},{"key":"ref741","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1373\/clinchem.2008.113373","article-title":"Processing of pro-brain natriuretic peptide is suppressed by O-glycosylation in the region close to the cleavage site","volume":"55","year":"2009","journal-title":"Clin Chem"},{"key":"ref1961","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1161\/CIRCULATIONAHA.115.017298","article-title":"NT-proBNP and heart failure risk among individuals with and without obesity: the ARIC study","volume":"133","year":"2016","journal-title":"Circulation"},{"key":"ref591","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/HJH.0b013e3282f624a0","article-title":"Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans","volume":"26","year":"2008","journal-title":"J Hypertens"},{"key":"ref1241","first-page":"143","article-title":"Caloric restriction for treatment of geriatric obesity: do the benefits outweigh the risks?","volume":"4","year":"2015","journal-title":"Curr Opin Cardiol"},{"key":"ref1291","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/HYPERTENSIONAHA.111.190223","article-title":"Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction","volume":"59","year":"2012","journal-title":"Hypertension"},{"key":"ref651","first-page":"B37","article-title":"Nonenzymatic glycosylation: role in the pathogenesis of diabetic complications","volume":"32","year":"1986","journal-title":"Clin Chem"},{"key":"ref751","first-page":"832","article-title":"Assay of brain natriuretic peptide (BNP) in human plasma: evidence for high molecular weight BNP as a major plasma component in heart failure","volume":"76","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"ref971","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1161\/CIRCULATIONAHA.115.017298","article-title":"NT-proBNP and heart failure risk among individuals with and without obesity: the ARIC study","volume":"133","year":"2016","journal-title":"Circulation"},{"key":"ref531","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.cca.2012.07.017","article-title":"State of the art of BNP and NT-proBNP immunoassays: the CardioOrmoCheck study","volume":"414","year":"2012","journal-title":"Clin Chim Acta"},{"key":"ref1071","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jacc.2010.04.040","article-title":"Hemodynamic basis of exercise limitation in patients with heart failure and normal ejection fraction","volume":"56","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"ref1341","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1161\/CIRCRESAHA.115.307765","article-title":"Increased epicardial adipose tissue volume correlates with cardiac sympathetic denervation in patients with heart failure","volume":"118","year":"2016","journal-title":"Circ Res"},{"key":"ref1451","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.amjcard.2012.05.014","article-title":"Prevalence, clinical phenotype, and outcomes associated with normal B-type natriuretic peptide levels in heart failure with preserved ejection fraction","volume":"110","year":"2012","journal-title":"Am J Cardiol"},{"key":"ref1211","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jacc.2016.05.019","article-title":"The HFpEF obesity phenotype. The elephant in the room","volume":"68","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"ref1701","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.abb.2006.03.028","article-title":"The precursor to B-type natriuretic peptide is an O-linked glycoprotein","volume":"451","year":"2006","journal-title":"Arch Biochem Biophys"},{"key":"ref1481","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0140-6736(94)92690-5","article-title":"Plasma brain natriuretic peptide in assessment of acute dyspnoea","volume":"343","year":"1994","journal-title":"Lancet"},{"key":"ref681","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1373\/clinchem.2007.090266","article-title":"Analysis of circulating forms of proBNP and NT-proBNP in patients with severe heart failure","volume":"54","year":"2008","journal-title":"Clin Chem"},{"key":"ref1181","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.clinthera.2015.08.005","article-title":"Management of heart failure with preserved ejection fraction: a review","volume":"37","year":"2015","journal-title":"Clin Ther"},{"key":"ref1771","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1373\/clinchem.2007.097998","article-title":"Cross-reactivity of BNP, NT-proBNP, and proBNP in commercial BNP and NT-proBNP assays: preliminary observations from the IFCC Committee for Standardization of Markers of Cardiac Damage","volume":"54","year":"2008","journal-title":"Clin Chem"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.bbalip.2009.09.023","article-title":"Lipotoxicity in the heart","volume":"1801","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"ref1201","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1093\/eurheartj\/ehu204","article-title":"New strategies for heart failure with preserved ejection fraction: the importance of targeted therapies for heart failure phenotypes","volume":"35","year":"2014","journal-title":"Eur Heart J"},{"key":"ref1891","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1249\/01.mss.0000170124.51659.52","article-title":"Training enhances ANP lipid-mobilizing action in adipose tissue of overweight men","volume":"37","year":"2005","journal-title":"Med Sci Sports Exercise"},{"key":"ref1151","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.cardfail.2011.01.013","article-title":"High prevalence of sleep apnea in heart failure outpatients: even in patients with preserved systolic function","volume":"17","year":"2011","journal-title":"J Card Fail"},{"key":"ref871","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1038\/oby.2011.296","article-title":"Brain Natriuretic Peptide Subgroup of the Look AHEAD Research Group. Impact of the Look AHEAD intervention on NT-pro brain natriuretic peptide in overweight and obese adults with diabetes","volume":"20","year":"2012","journal-title":"Obesity Res"},{"key":"ref1561","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s10741-011-9249-z","article-title":"The paradox of low BNP levels in obesity","volume":"17","year":"2012","journal-title":"Heart Fail Rev"},{"key":"ref1101","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1152\/physrev.00017.2007","article-title":"Cardiac remodeling in obesity","volume":"88","year":"2008","journal-title":"Physiol Rev"},{"key":"ref1171","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1056\/NEJMoa020245","article-title":"Obesity and the risk of heart failure","volume":"347","year":"2002","journal-title":"N Engl J Med"},{"key":"ref281","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10741-012-9337-8","article-title":"Direct effects of adipokines on the heart: focus on adiponectin","volume":"18","year":"2013","journal-title":"Heart Fail Rev"},{"key":"ref721","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1373\/clinchem.2007.100040","article-title":"Immunodetection of glycosylated NT-proBNP circulating in human blood","volume":"54","year":"2008","journal-title":"Clin Chem"},{"key":"ref791","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1515\/cclm-2017-0433","article-title":"New issue on measurement of B-type natriuretic peptides","volume":"56","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"ref1271","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s10741-012-9337-8","article-title":"Direct effects of adipokines on the heart: focus on adiponectin","volume":"18","year":"2013","journal-title":"Heart Fail Rev"},{"key":"ref1601","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jacc.2011.03.042","article-title":"Influence of sex and hormone status on circulating natriuretic peptides","volume":"58","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"ref771","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1373\/clinchem.2016.265397","article-title":"Unraleveling the molecular complexity of O-glycosylated endogenous (N-Terminal) pro_B-type natriuretic peptide forms in blood plasma of patients with severe heart failure","volume":"63","year":"2017","journal-title":"Clin Chem"},{"key":"ref661","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.jacc.2006.10.063","article-title":"Evidence for functional heterogeneity of circulating B-type natriuretic peptide","volume":"49","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"ref1351","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.bbalip.2009.09.023","article-title":"Lipotoxicity in the heart","volume":"1801","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"ref821","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","year":"2008","journal-title":"N Engl J Med"},{"key":"ref1531","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cca.2014.06.003","article-title":"Cardiac biomarker testing in the clinical laboratory: where do we stand? General overview of the methodology with special emphasis on natriuretic peptides","volume":"443","year":"2015","journal-title":"Clin Chim Acta"},{"key":"ref1911","doi-asserted-by":"crossref","first-page":"E246","DOI":"10.1152\/ajpendo.00688.2006","article-title":"The atrial natriuretic peptide- and catecholamine-induced lipolysis and expression of related genes in adipose tissue in hypothyroid and hyperthyroid patients","volume":"293","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref311","doi-asserted-by":"crossref","first-page":"46","DOI":"10.5049\/EBP.2013.11.2.46","article-title":"Obesity associated hypertension: new insights into mechanism","volume":"11","year":"2013","journal-title":"Electrolyte Blood Press"},{"key":"ref101","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1001\/jama.1991.03470020057032","article-title":"The impact of obesity on left ventricular mass and geometry. The Framingham Heart Study","volume":"266","year":"1991","journal-title":"J Am Med Assoc"},{"key":"ref481","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/BF03347297","article-title":"Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure","volume":"21","year":"1998","journal-title":"J Endocrinol Invest"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jacc.2016.04.052","article-title":"Functional status, pulmonary artery pressure, and clinical outcomes in heart failure with preserved ejection fraction","volume":"68","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"ref941","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1158\/0008-5472.CAN-06-4585","article-title":"Mechanism of increased lipolysis in cancer cachexia","volume":"67","year":"2007","journal-title":"Cancer Res"},{"key":"ref851","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.jacc.2013.03.038","article-title":"Higher natriuretic peptide levels associate with a favorable adipose tissue distribution profile","volume":"62","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"e540","DOI":"10.1016\/j.orcp.2013.12.005","article-title":"Mechanisms of heart failure in obesity","volume":"8","year":"2014","journal-title":"Obes Res Clin Pract"},{"key":"ref891","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1096\/fj.03-1086fje","article-title":"Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans","volume":"18","year":"2004","journal-title":"FASEB J"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1152\/physrev.00017.2007","article-title":"Cardiac remodeling in obesity","volume":"88","year":"2008","journal-title":"Physiol Rev"},{"key":"ref1651","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.jacc.2006.10.063","article-title":"Evidence for functional heterogeneity of circulating B-type natriuretic peptide","volume":"49","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/CIRCULATIONAHA.117.028365","article-title":"Obese heart failure with preserved ejection fraction phenotype: from pariah to central player","volume":"136","year":"2017","journal-title":"Circulation"},{"key":"ref881","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.biochi.2015.05.017","article-title":"Natriuretic peptide control of energy balance and glucose homeostasis","volume":"124","year":"2016","journal-title":"Biochimie"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1016\/j.clinthera.2015.08.005","article-title":"Management of heart failure with preserved ejection fraction: a review","volume":"37","year":"2015","journal-title":"Clin Ther"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.jacc.2010.04.040","article-title":"Hemodynamic basis of exercise limitation in patients with heart failure and normal ejection fraction","volume":"56","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"552","DOI":"10.3945\/ajcn.112.047860","article-title":"Associations between body composition and gait-speed decline: results from the Health, Aging, and Body Composition study","volume":"97","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"ref1751","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cca.2015.07.004","article-title":"B-type Natriuretic Peptide circulating forms: analytical and bioactivity issues","volume":"448","year":"2015","journal-title":"Clin Chim Acta"},{"key":"ref1631","doi-asserted-by":"crossref","first-page":"527","DOI":"10.7326\/0003-4819-101-4-527","article-title":"Nonenzymatic glycosylation and the pathogenesis of diabetic complications","volume":"101","year":"1984","journal-title":"Ann Intern Med"},{"key":"ref961","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.pharmthera.2014.04.007","article-title":"Metabolic actions of natriuretic peptides and therapeutic potential in the metabolic syndrome","volume":"144","year":"2014","journal-title":"Pharmacol Ther"},{"key":"ref981","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ijcard.2016.04.111","article-title":"Potent influence of obesity on suppression of plasma B-type natriuretic peptide levels in patients with acute heart failure: an approach using covariance structure analysis","volume":"215","year":"2016","journal-title":"Int J Cardiol"},{"key":"ref921","doi-asserted-by":"crossref","first-page":"E246","DOI":"10.1152\/ajpendo.00688.2006","article-title":"The atrial natriuretic peptide- and catecholamine-induced lipolysis and expression of related genes in adipose tissue in hypothyroid and hyperthyroid patients","volume":"293","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref1811","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMoa0805450","article-title":"Irbesartan in patients with heart failure and preserved ejection fraction","volume":"359","year":"2008","journal-title":"N Engl J Med"},{"key":"ref251","first-page":"143","article-title":"Caloric restriction for treatment of geriatric obesity: do the benefits outweigh the risks?","volume":"4","year":"2015","journal-title":"Curr Opin Cardiol"},{"key":"ref511","doi-asserted-by":"crossref","first-page":"D102","DOI":"10.1093\/eurheartj\/sux027","article-title":"ANMCO\/ELAS\/SIBioC consensus document: biomarkers in heart failure","volume":"19","year":"2017","journal-title":"Eur Heart J Suppl"},{"key":"ref521","first-page":"762","article-title":"Proficiency testing project for brain natriuretic peptide (BNP) and the N-terminal part of the propeptide of BNP (NT-proBNP) immunoassays: the CardioOrmocheck study","volume":"47","year":"2009","journal-title":"Clin Chem Lab Med"},{"key":"ref271","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1001\/jama.2015.17346","article-title":"Effect of caloric restriction or aerobic exercise training on peak oxygen consumption and quality of life in obese older patients with heart failure and preserved ejection fraction a randomized, controlled trial","volume":"315","year":"2016","journal-title":"J Am Med Assoc"},{"key":"ref1571","doi-asserted-by":"crossref","first-page":"H12","DOI":"10.1152\/ajpheart.00226.2011","article-title":"60. Thirty years of the heart as an endocrine organ: physiological role and clinical utility of cardiac natriuretic hormones","volume":"301","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref541","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.cca.2014.06.003","article-title":"Cardiac biomarker testing in the clinical laboratory: where do we stand? General overview of the methodology with special emphasis on natriuretic peptides","volume":"443","year":"2015","journal-title":"Clin Chim Acta"},{"key":"ref1831","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S0140-6736(03)14285-7","article-title":"CHARM Investigators and Committees. Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial","volume":"362","year":"2003","journal-title":"Lancet"},{"key":"ref1941","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1172\/JCI59701","article-title":"Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes","volume":"122","year":"2012","journal-title":"J Clin Invest"},{"key":"ref621","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2006.10.040","article-title":"Associations among androgens, estrogens, and natriuretic peptides in young women: observations from the Dallas Heart Study","volume":"49","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"ref1411","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.jacc.2013.11.035","article-title":"Risk of myocardial infarction and heart failure among metabolically healthy but obese individuals. The HUNT Study, Norway","volume":"63","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"ref761","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.cca.2015.07.004","article-title":"B-type Natriuretic Peptide circulating forms: analytical and bioactivity issues","volume":"448","year":"2015","journal-title":"Clin Chim Acta"},{"key":"ref1131","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1016\/j.jacc.2014.08.036","article-title":"Noncardiac comorbidities in heart failure with reduced versus preserved ejection fraction","volume":"64","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"ref1471","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/BF03347297","article-title":"Circulating levels of cardiac natriuretic peptides (ANP and BNP) measured by highly sensitive and specific immunoradiometric assays in normal subjects and in patients with different degrees of heart failure","volume":"21","year":"1998","journal-title":"J Endocrinol Invest"},{"key":"ref1881","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1096\/fj.03-1086fje","article-title":"Atrial natriuretic peptide contributes to physiological control of lipid mobilization in humans","volume":"18","year":"2004","journal-title":"FASEB J"},{"key":"ref1401","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1161\/CIRCULATIONAHA.106.632745","article-title":"Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction","volume":"114","year":"2006","journal-title":"Circulation"},{"key":"ref1931","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1158\/0008-5472.CAN-06-4585","article-title":"Mechanism of increased lipolysis in cancer cachexia","volume":"67","year":"2007","journal-title":"Cancer Res"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S1388-1981(02)00342-6","article-title":"Lipoapoptosis: its mechanism and its diseases","volume":"1585","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrcardio.2014.83","article-title":"The pathophysiology of heart failure with preserved ejection fraction","volume":"11","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"ref1221","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/j.amjcard.2013.12.031","article-title":"Skeletal muscle composition and its relation to exercise intolerance in older patients with heart failure and preserved ejection fraction","volume":"113","year":"2014","journal-title":"Am J Cardiol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1002\/ejhf.110","article-title":"Prevalence of unrecognized heart failure in older persons with shortness of breath on exertion","volume":"16","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"ref861","doi-asserted-by":"crossref","first-page":"e0181212","DOI":"10.1371\/journal.pone.0181212","article-title":"Short term variation in NTproBNP after lifestyle intervention in severe obesity","volume":"12","year":"2017","journal-title":"PLoS One"},{"key":"ref301","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1161\/HYPERTENSIONAHA.111.190223","article-title":"Adipocytes produce aldosterone through calcineurin-dependent signaling pathways: implications in diabetes mellitus-associated obesity and vascular dysfunction","volume":"59","year":"2012","journal-title":"Hypertension"},{"key":"ref1781","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1515\/cclm-2017-0433","article-title":"New issue on measurement of B-type natriuretic peptides","volume":"56","year":"2017","journal-title":"Clin Chem Lab Med"},{"key":"ref471","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1093\/clinchem\/42.10.1627","article-title":"Analytical performance and clinical usefulness of a commercially available IRMA kit for the measurement of atrial natriuretic peptide in patients with heart failure","volume":"42","year":"1996","journal-title":"Clin Chem"},{"key":"ref1061","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/CIRCHEARTFAILURE.109.930701","article-title":"Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction","volume":"3","year":"2010","journal-title":"Circ Heart Fail"},{"key":"ref1021","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cpcardiol.2015.12.002","article-title":"Heart failure with preserved ejection fraction","volume":"41","year":"2016","journal-title":"Curr Probl Cardiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cpcardiol.2015.12.002","article-title":"Heart failure with preserved ejection fraction","volume":"41","year":"2016","journal-title":"Curr Probl Cardiol"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jchf.2013.01.006","article-title":"Impact of obesity and the obesity paradox on prevalence and prognosis in heart failure","volume":"1","year":"2013","journal-title":"JACC Heart Fail"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/CIRCHEARTFAILURE.109.930701","article-title":"Exercise hemodynamics enhance diagnosis of early heart failure with preserved ejection fraction","volume":"3","year":"2010","journal-title":"Circ Heart Fail"},{"key":"ref1121","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1038\/nrcardio.2014.83","article-title":"The pathophysiology of heart failure with preserved ejection fraction","volume":"11","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"ref1921","first-page":"1119","article-title":"Lipolytic effects of B-type natriuretic peptide 1-32 in adipose tissue of heart failure patients compared with healthy controls","volume":"58","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"ref691","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/j.jacc.2011.01.005","article-title":"Pro-B-type natriuretic peptide 1-108 circulates in the general community: plasma determinants and detection of left ventricular systolic dysfunction","volume":"57","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"ref551","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.hfc.2014.04.006","article-title":"Natriuretic peptides in heart failure with preserved ejection fraction","volume":"10","year":"2014","journal-title":"Heart Fail Clin"},{"key":"ref1141","first-page":"85","article-title":"A clinical approach to obstructive sleep apnea as a risk factor for cardiovascular disease","volume":"12","year":"2016","journal-title":"Vasc Health Risk Manag"},{"key":"ref1851","doi-asserted-by":"crossref","first-page":"e0181212","DOI":"10.1371\/journal.pone.0181212","article-title":"Short term variation in NTproBNP after lifestyle intervention in severe obesity","volume":"12","year":"2017","journal-title":"PLoS One"},{"key":"ref1001","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/eurjhf\/hfr036","article-title":"Heart failure diagnosis and prognosis in the elderly: the proof of the pudding is in the eating","volume":"13","year":"2011","journal-title":"Eur J Heart Fail"},{"key":"ref1821","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1093\/eurheartj\/ehl250","article-title":"The perindopril in elderly people with chronic heart failure (PEP-CHF) study","volume":"27","year":"2006","journal-title":"Eur Heart J"},{"key":"ref321","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1515\/hmbci-2014-0013","article-title":"Crosstalk between adipose tissue and blood vessels in cardiometabolic syndrome: implication of steroid hormone receptors (MR\/GR)","volume":"19","year":"2014","journal-title":"Horm Mol Biol Clin Investig"}],"container-title":["Clinical Chemistry and Laboratory Medicine (CCLM)"],"original-title":[],"link":[{"URL":"http:\/\/www.degruyter.com\/view\/j\/cclm.2018.56.issue-7\/cclm-2017-0840\/cclm-2017-0840.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2017-0840\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T20:24:48Z","timestamp":1719779088000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/cclm-2017-0840\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,27]]},"references-count":194,"journal-issue":{"issue":"7"},"URL":"https:\/\/doi.org\/10.1515\/cclm-2017-0840","relation":{},"ISSN":["1437-4331","1434-6621"],"issn-type":[{"value":"1437-4331","type":"electronic"},{"value":"1434-6621","type":"print"}],"subject":[],"published":{"date-parts":[[2018,6,27]]}}}